Setterwalls advised Guard Therapeutics on the deal. Guard Therapeutics International AB (publ) secured a private placement in the form of a directed share issue of approximately...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Doxa and Serneke in the deal. Doxas wholly owned subsidiary Serneke divested together with Balder approximately 151 000 square meters of development rights in...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Crunchfish AB on the deal. Crunchfish AB successfully concluded a share rights issue, generating approximately SEK 51 million in proceeds before factoring in issue...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Iconovo on the deal. conovo AB has carried out a private placement of SEK 55 million through a directed new issue of 1,375,000...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Guard Therapeutics on the deal. Guard Therapeutics International AB announced private placement of approximately SEK 120 million. Guard Therapeutics International AB (publ) is a...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised InCoax Networks AB on the deal. InCoax Networks AB announced a rights issue that was subscribed to approximately 120.6 percent, and a subsequent...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Qlife Holding on the deal. Qlife Holding announced a rights issue of units, consisting of shares and warrants. Qlife Holding develops and markets...
You must be a Standard 1 Year member to access this content.
Sidley and Setterwalls advised inriver on the deal. Hannes Snellman advised Thomas H. Lee Partners. Inriver, a company that empowers organizations to deliver revenue-driving product information...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Guard Therapeutics International AB on the deal. Guard Therapeutics International AB (publ) announced a private placement through a directed new issue of approximately...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Aptahem AB. Aptahem AB announced a rights issue of units, consisting of shares and warrants. Aptahem is a biotechnology company that develops aptamer-based...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised WntResearch on the deal. WntResearch AB announced a rights issue of units, consisting of shares and warrants. Through the rights issue, WntResearch AB receives...
You must be a Standard 1 Year member to access this content.
